[Clinical Value of Cardiovascular Calcifications on Non-Enhanced, Non-ECG-Gated Chest CT].
Tae Seop ChoiHwan Seok YongCherry KimYoung Joo SuhPublished in: Taehan Yongsang Uihakhoe chi (2020)
Cardiovascular calcifications can occur in various cardiovascular diseases and can serve as a biomarker for cardiovascular event prediction. Advances in CT have enabled evaluation of calcifications in cardiovascular structures not only on ECG-gated CT but also on non-ECG-gated CT. Therefore, many studies have been conducted on the clinical relevance of cardiovascular calcifications in patients. In this study, we divided cardiovascular calcifications into three classes, i.e., coronary artery, thoracic aorta, and cardiac valve calcifications, which are closely associated with cardiovascular events. Further, we briefly described pericardial calcifications, which can be found incidentally. Since the start of lung cancer screening in Korea in the second half of 2019, the number of non-enhanced, non-ECG-gated, low-dose chest CT has been increasing, and the number of incidentally found cardiovascular calcifications has also been increasing. Therefore, understanding the relevance of cardiovascular calcifications on non-enhanced, non-ECG-gated, low-dose chest CT and their proper reporting are important for radiologists.
Keyphrases
- low dose
- image quality
- computed tomography
- dual energy
- contrast enhanced
- cardiovascular events
- coronary artery
- heart rate variability
- heart rate
- end stage renal disease
- magnetic resonance
- magnetic resonance imaging
- chronic kidney disease
- blood pressure
- ejection fraction
- high dose
- newly diagnosed
- type diabetes
- spinal cord injury
- mitral valve
- high resolution
- metabolic syndrome
- mass spectrometry
- prognostic factors
- transcatheter aortic valve replacement
- pet ct
- cardiovascular risk factors
- aortic dissection
- patient reported